Petri Ingman
****************************************************************************
>
>NMR SCIENTIST - POSITION OPEN
>
>Orion Corporation
>ORION PHARMA
>Preclinical Research
>P.O.box 65 FIN-02101 Espoo
>Finland
>
>The Orion Group is the leading company in the Finnish health care
>sector. The pharmaceutical division, Orion Pharma, is seeking a
>substantial role in pharmaceuticals in Europe. This aim is pursued by
>developing competitive products through in-house R & D for specific
>areas, and by strengthening and expanding the present market position.
>Our future success will be driven by highly competent and committed
>scientists and specialists working together in teams.
>
>In the Structural Chemistry Laboratory of the Preclinical Research a
>position is open for a research scientist specialized in NMR
>spectroscopy
>
>A qualified candidate has a Ph.D. and research experience in liquid NMR,
>with documented skills in multidimensional heteronuclear NMR
>spectroscopy, preferably with experience in protein structure
>determination and screening methodologies. A background in biochemistry,
>or molecular biology is desirable, as well the familiarity with software
>such as InsightII and FELIX (Molecular Simulations) and with UNIX/SGI in
>general. An excellent interpersonal and networking skills and fluency in
>English are also required.
>
>The successful candidate will work on two Bruker NMR spectrometers
>(AC300, ARX400 Mhz with z-gradient) located at the Orion Research Center
>in Espoo (Helsinki metropolitan area) and will cooperate with a team of
>research scientists involved in the drug discovery process. He/she will
>be responsable for studies on the fine structure of products, the
>structure of peptides and proteins, the drug target-ligand interactions
>and binding characterization. He/she will eventually perform also
>metabolic studies on isolated perfused organs and detection and
>quantification of metabolites and xenobiotics in biological fluids or
>extracts. Moreover, he/she will take part in research cooperation with
>academic groups studying protein and protein-ligand structures with
>higher field spectrometers.
>
>Salary level will be commensurate with qualifications and experience.
>Applicants should submit a curriculum vitae, including list of
>publications and a description of their present research activity, to
>Dr.Martti Ovaska, Orion Pharma, Preclinical Research, P.O.box 65,
>FIN-02101 Espoo, Finland before September, 6, 1998. For further
>information, contact Dr.Martti Ovaska, Manager of the Structural
>Chemistry Laboratory , at int-358-9-429-2536 (e-mail:
>martti.ovaska@orion.mailnet.fi) or Dr.Piero Pollesello, Head of
>Cardiovascular Preclinical Research, at int-358-9-429-4191 (e-mail:
>piero.pollesello@orion.mailnet.fi), FAX:int-358-9-429-2924.
>
>
*************************************************************************
Dr. Petri Ingman tel: +358-8-553 1606
NMR Facility Manager fax: +358-8-553 1603
University of Oulu e-mail:petri.ingman@oulu.fi
Oulu, FINLAND
*************************************************************************